JP2011518212A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518212A5
JP2011518212A5 JP2011505547A JP2011505547A JP2011518212A5 JP 2011518212 A5 JP2011518212 A5 JP 2011518212A5 JP 2011505547 A JP2011505547 A JP 2011505547A JP 2011505547 A JP2011505547 A JP 2011505547A JP 2011518212 A5 JP2011518212 A5 JP 2011518212A5
Authority
JP
Japan
Prior art keywords
psoriasis
treatment
route
disease
joints
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011505547A
Other languages
English (en)
Japanese (ja)
Other versions
JP5536037B2 (ja
JP2011518212A (ja
Filing date
Publication date
Priority claimed from FR0802220A external-priority patent/FR2930156B1/fr
Application filed filed Critical
Publication of JP2011518212A publication Critical patent/JP2011518212A/ja
Publication of JP2011518212A5 publication Critical patent/JP2011518212A5/ja
Application granted granted Critical
Publication of JP5536037B2 publication Critical patent/JP5536037B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011505547A 2008-04-21 2009-04-15 自己免疫疾患の治療における、ｐａｔノナペプチドの使用 Expired - Fee Related JP5536037B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0802220A FR2930156B1 (fr) 2008-04-21 2008-04-21 Utilisation du nonapeptide pat dans le traitement des maladies autoimmunes.
FR0802220 2008-04-21
PCT/FR2009/000439 WO2009150310A1 (fr) 2008-04-21 2009-04-15 Utilisation du nonapeptide pat dans le traitement de maladies autoimmunes

Publications (3)

Publication Number Publication Date
JP2011518212A JP2011518212A (ja) 2011-06-23
JP2011518212A5 true JP2011518212A5 (https=) 2012-05-31
JP5536037B2 JP5536037B2 (ja) 2014-07-02

Family

ID=40024222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011505547A Expired - Fee Related JP5536037B2 (ja) 2008-04-21 2009-04-15 自己免疫疾患の治療における、ｐａｔノナペプチドの使用

Country Status (6)

Country Link
US (1) US9427455B2 (https=)
EP (1) EP2265279B1 (https=)
JP (1) JP5536037B2 (https=)
FR (1) FR2930156B1 (https=)
PL (1) PL2265279T3 (https=)
WO (1) WO2009150310A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2962335B1 (fr) * 2010-07-12 2013-01-18 Cll Pharma Utilisation du nonapeptide pat dans le traitement et la prevention des maladies neurodegeneratives
US9468662B2 (en) 2010-07-12 2016-10-18 Orphit Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7502830A (nl) * 1974-03-25 1975-09-29 Jean Francois Bach En Dr Jean Werkwijze voor het isoleren van een polypeptide hormoon.
US4098777A (en) * 1977-03-14 1978-07-04 Merck & Co., Inc. Process for the preparation of pyroglutamyl-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn
GB1572889A (en) * 1977-05-25 1980-08-06 Inst Nat Sante Rech Med Polypeptides
GR75636B (https=) * 1980-05-22 1984-08-02 Inst Nat Sante Rech Med
JPS5852225A (ja) 1981-09-22 1983-03-28 Mitsui Pharmaceut Inc 脱髄疾患治療剤
US5808009A (en) * 1996-09-23 1998-09-15 North Dakota State University Research Foundation Method of affinity purifying antibodies
FR2830451B1 (fr) * 2001-10-09 2004-04-30 Inst Nat Sante Rech Med Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur

Similar Documents

Publication Publication Date Title
CA3029478A1 (en) Use of neurokinin-1 antagonists to treat a variety of pruritic conditions
BR0008060A (pt) Composições inibidoras de ciclooxigenase-2 tendo rápido inìcio de eficácia terapêutica
ATE477804T1 (de) Verfahren zur behandlung von entzündlichen erkrankungen des verdauungstrakts mit topisch wirksamen kortikosteroiden
RU2002121546A (ru) Вещества, предназначенные для лечения псориаза
CN101677984A (zh) 地来西坦在治疗慢性疼痛中的应用
CN1170592C (zh) 美拉加林的新用途
EA200900868A1 (ru) КОМБИНИРОВАННАЯ ТЕРАПИЯ ЗАБОЛЕВАНИЙ НИЖНИХ МОЧЕВЫВОДЯЩИХ ПУТЕЙ С ИСПОЛЬЗОВАНИЕМ ЛИГАНДОВ α2δ И НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ПРЕПАРАТОВ (НПВП)
Szczeklik et al. Choline magnesium trisalicylate in patients with aspirin-induced asthma
JP2011518212A5 (https=)
FI4255563T3 (fi) 5’-o-fenyyliasetyyliuridiini ja terapeuttinen käyttö
RU2007138263A (ru) Противовоспалительные соединения
JP2008533079A5 (https=)
CN1617719A (zh) 包含p－gp抑制剂和抗癫痫药物的组合
WO2004108110A1 (en) Sublingual administration of non-steroidal anti-inflammatory pharmacological substances
JP5536037B2 (ja) 自己免疫疾患の治療における、ｐａｔノナペプチドの使用
JP4863437B2 (ja) 浴用フィルム製剤
EP1656135A1 (en) Method and composition for treating burned skin
US11813237B2 (en) Creatine, its derivatives, compositions and methods of use thereof
WO2020145811A1 (es) Composición farmacéutica sinérgica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumáticas o dolor postquirúrgico
CN104000814A (zh) 一种防治痛风性关节炎的药物组合物及其用途
KR960033468A (ko) 혈전용해 치료를 받지않은 환자에서 히루딘 및 아세틸살리실산으로 급성 심근 경색을 치료하는 방법
WO1999025382A1 (en) Pharmaceutical combination of a cyclooxygenase-2 inhibitor
Mbanefo et al. MP47-11 DOWNREGULATION OF PRO-INFLAMMATORY PATHWAYS BY IPSE, A UROGENITAL PARASITE-DERIVED IMMUNOMODULATORY PROTEIN, REDUCES IFOSFAMIDE-INDUCED HEMORRHAGIC CYSTITIS
CN106572969A (zh) 用于治疗银屑病的药物组合物
US20080076827A1 (en) Treatment of Inflammatory Bowel Disease